The conference programme will include:
Is it the end of the road for MDIs?
Can we improve the way we perform clinical trials.
Parallel Multiple drug/device development.
Globalising the Breezehaler.
Novel Inhalation Therapy.
EMA OIP Guidance.
Emerging Markets: Inhalation products for asthma COPD in China.
Formulation: Inhalation strategies to treat respiratory infections.
Technology: Investigating the output of different inhalers and Nicotine inhalers.
The conference will be chaired by Dr Steve Nichols, OINDP Specialist Consultant.
Keynote Address COPD: New Drug Developments by Professor Peter Barnes National Heart and Lung Institute.